Total Payments
$1,635
2024 Payments
$654.59
Companies
11
Transactions
44
Medicare Patients
3,388
Medicare Billing
$420,485
Payment Breakdown by Category
Food & Beverage$1,635 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,635 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $480.81 | 11 | $0 (2024) |
| Lilly USA, LLC | $444.55 | 8 | $0 (2024) |
| ABBVIE INC. | $187.37 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $131.44 | 6 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $110.62 | 2 | $0 (2022) |
| Inspire Medical Systems, Inc. | $91.60 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $50.95 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $45.28 | 2 | $0 (2024) |
| Rhythm Pharmaceuticals, Inc. | $40.36 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $32.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $654.59 | 21 | Lilly USA, LLC ($232.73) |
| 2023 | $538.03 | 15 | Novo Nordisk Inc ($218.27) |
| 2022 | $442.63 | 8 | Novo Nordisk Inc ($212.01) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $36.15 | General |
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: VACCINE | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $69.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $91.60 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $53.04 | General |
| Category: Obesity | ||||||
| 01/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Diabetes | ||||||
| 10/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.37 | General |
| 10/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $64.63 | General |
| Category: Diabetes | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: VACCINE | ||||||
| 09/21/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 745 | 1,117 | $300,194 | $80,369 |
| 2022 | 15 | 1,157 | 1,694 | $453,039 | $143,592 |
| 2021 | 13 | 713 | 1,098 | $356,824 | $95,357 |
| 2020 | 11 | 773 | 1,224 | $366,308 | $101,168 |
Total Patients
3,388
Total Services
5,133
Medicare Billing
$420,485
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 206 | $92,350 | $19,752 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 81 | $46,200 | $10,022 | 21.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 155 | 169 | $18,590 | $9,731 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $44,700 | $9,132 | 20.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 146 | 368 | $27,220 | $8,973 | 33.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 87 | 88 | $22,000 | $8,939 | 40.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 49 | 52 | $20,800 | $7,212 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $12,350 | $2,540 | 20.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 26 | 27 | $5,400 | $2,119 | 39.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 22 | $5,808 | $1,114 | 19.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 12 | $4,776 | $835.47 | 17.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 257 | 287 | $113,960 | $35,504 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 94 | 228 | $113,046 | $31,315 | 27.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 275 | 347 | $38,170 | $20,722 | 54.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 68 | 68 | $43,651 | $10,161 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $36,460 | $9,073 | 24.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 134 | 356 | $17,800 | $9,069 | 50.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 60 | 72 | $14,690 | $7,438 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 59 | $21,697 | $5,232 | 24.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 54 | $18,036 | $4,224 | 23.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 65 | $15,001 | $3,520 | 23.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 26 | 26 | $6,700 | $2,583 | 38.5% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Facility | 2022 | 13 | 13 | $5,200 | $1,951 | 37.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 17 | 17 | $3,605 | $1,187 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 12 | $4,073 | $904.08 | 22.2% |
About Dr. Ee Wan, MD
Dr. Ee Wan, MD is a Internal Medicine healthcare provider based in Medford, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558532317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ee Wan, MD has received a total of $1,635 in payments from pharmaceutical and medical device companies, with $654.59 received in 2024. These payments were reported across 44 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,635).
As a Medicare-enrolled provider, Wan has provided services to 3,388 Medicare beneficiaries, totaling 5,133 services with total Medicare billing of $420,485. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Medford, OR
- Active Since 03/19/2008
- Last Updated 11/27/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558532317
Products in Payments
- MOUNJARO (Drug) $391.51
- Wegovy (Drug) $285.63
- CREON (Drug) $141.05
- FARXIGA (Drug) $115.39
- Kerendia (Drug) $110.62
- INSPIRE (Device) $91.60
- ZEPBOUND (Drug) $53.04
- REXULTI (Drug) $50.95
- Ozempic (Drug) $43.93
- Imcivree (Drug) $40.36
- Rybelsus (Drug) $35.51
- TRELEGY ELLIPTA (Drug) $32.84
- LINZESS (Drug) $27.54
- GARDASIL (Biological) $27.09
- VOQUEZNA (Drug) $19.43
- VIBERZI (Drug) $18.78
- GARDASIL 9 (Biological) $18.19
- AIRSUPRA (Drug) $16.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Medford
Dr. James Holton, Md, MD
Internal Medicine — Payments: $52,935
Internal Medicine $52,935
Dr. Jane Jaffe, D.o, D.O
Internal Medicine — Payments: $11,965
Internal Medicine $11,965
Poorav Patel, Md, Mhs, MD, MHS
Internal Medicine — Payments: $8,848
Internal Medicine $8,848
Alyssa Corley, Md, MD
Internal Medicine — Payments: $8,415
Internal Medicine $8,415
Dr. Joseph Hickey, Md, MD
Internal Medicine — Payments: $7,710
Internal Medicine $7,710
Rohit Malhotra, M.d, M.D
Internal Medicine — Payments: $6,720
Internal Medicine $6,720